共 65 条
- [1] Afanas’eva M.A.(2008)Proliferative Response of Concanavalin A-Activated Thymus and Spleen Lymphocytes in the Ontogeny of Brattleboro Rats with a Genetic Defect of Vasopressin Synthesis Dokl. Biol. Sci. 420 153-154
- [2] Mel’nikova V.I.(1997)The Selection of Tumor Variants with Altered Expression of Classical and Nonclassical MHC Class I Molecules: Implications for Tumor Immune Escape Int. J. Clin. Lab. Res. 27 95-102
- [3] Voronova S.N.(1984)Biochemical Markers in Inbred Strains of the Rat ( Immunogenetics 19 257-266
- [4] Algarra I.(2003)) Tissue Antigens 61 211-219
- [5] Collado A.(1994)Total Loss of MHC Class I in Colorectal Tumors Can Be Explained by Two Molecular Pathways: Beta2-Microglobulin Inactivation in MSI-Positive Tumors and LMP7/TAP2 Downregulation in MSI-Negative Tumors J. Neuroimmunol. 53 17-21
- [6] Garrido F.(2005)Contents of Corticotropin-Releasing Hormone and Arginine Vasopressin Immunoreactivity in the Spleen and Thymus during a Chronic Inflammatory Stress Imm. Rev. 207 145-157
- [7] Bender K.(2005)Mechanisms of MHC Class I-Restricted Antigen Processing and Cross-Presentation Exp. Cell Res. 308 422-438
- [8] Adams M.(1995)Role of Rho, Rac, and Rho-Kinase in Phosphorylation of Myosin Light Chain, Development of Polarity, and Spontaneous Migration of Walker 256 Carcinosarcoma Cells J. Neuroimmunol. 62 85-90
- [9] Baverstock P.R.(2001)Thymic Vasopressin (AVP) Transgene Expression in Rats: A Model for the Study of Thymic AVP Hyper-Expression in T Cell Differentiation Int. J. Cancer 191 366-372
- [10] Cabrera C.M.(2003)Systemic Deficits in Transporter for Antigen Presentation (TAP)-1 or Proteasome Subunit LMP2 Have Little or No Effect on Tumor Incidence Bull. Exp. Biol. Med. 136 448-450